A Belgian survey on the diagnosis of asthma–COPD overlap syndrome

Didier Cataldo,1 Jean-Louis Corhay,1 Eric Derom,2 Renaud Louis,1 Eric Marchand,3,4 Alain Michils,5 Vincent Ninane,6 Rudi Peché,7 Charles Pilette,8 Walter Vincken,9 Wim Janssens10 1Department of Respiratory Diseases, CHU Liège, University of Liège, Liège,...

Full description

Bibliographic Details
Main Authors: Cataldo D, Corhay JL, Derom E, Louis R, Marchand E, Michils A, Ninane V, Peché R, Pilette C, Vincken W, Janssens W
Format: Article
Language:English
Published: Dove Medical Press 2017-02-01
Series:International Journal of COPD
Subjects:
Online Access:https://www.dovepress.com/a-belgian-survey-on-the-diagnosis-of-asthmandashcopd-overlap-syndrome-peer-reviewed-article-COPD
id doaj-0045e8aa811745ecbd3ddf5aca673ecf
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Cataldo D
Corhay JL
Derom E
Louis R
Marchand E
Michils A
Ninane V
Peché R
Pilette C
Vincken W
Janssens W
spellingShingle Cataldo D
Corhay JL
Derom E
Louis R
Marchand E
Michils A
Ninane V
Peché R
Pilette C
Vincken W
Janssens W
A Belgian survey on the diagnosis of asthma–COPD overlap syndrome
International Journal of COPD
ACOS
airway obstruction
asthma
COPD
diagnosis
inhaled corticosteroids.
author_facet Cataldo D
Corhay JL
Derom E
Louis R
Marchand E
Michils A
Ninane V
Peché R
Pilette C
Vincken W
Janssens W
author_sort Cataldo D
title A Belgian survey on the diagnosis of asthma–COPD overlap syndrome
title_short A Belgian survey on the diagnosis of asthma–COPD overlap syndrome
title_full A Belgian survey on the diagnosis of asthma–COPD overlap syndrome
title_fullStr A Belgian survey on the diagnosis of asthma–COPD overlap syndrome
title_full_unstemmed A Belgian survey on the diagnosis of asthma–COPD overlap syndrome
title_sort belgian survey on the diagnosis of asthma–copd overlap syndrome
publisher Dove Medical Press
series International Journal of COPD
issn 1178-2005
publishDate 2017-02-01
description Didier Cataldo,1 Jean-Louis Corhay,1 Eric Derom,2 Renaud Louis,1 Eric Marchand,3,4 Alain Michils,5 Vincent Ninane,6 Rudi Peché,7 Charles Pilette,8 Walter Vincken,9 Wim Janssens10 1Department of Respiratory Diseases, CHU Liège, University of Liège, Liège, 2Department of Respiratory Medicine, Ghent University Hospital, Ghent, 3Department of Respiratory Medicine, CHU – UCL – Namur, Université catholique de Louvain, Yvoir, 4Molecular Physiology Research Unit (URPhyM)-NARILIS, Laboratory of General Physiology, University of Namur, Namur, 5Chest Department, Erasme University Hospital, Université Libre de Bruxelles, Brussels, 6Department of Respiratory Medicine, University Hospital Saint-Pierre, Université Libre de Bruxelles, Brussels, 7Department of Respiratory Medicine, University Hospital Vésale, Montigny-le-Tilleul, 8Department of Respiratory Medicine, Cliniques universitaires St Luc, Université Catholique de Louvain, Brussels, 9Respiratory Division, University Hospital Brussels (UZ Brussel), Vrije Universiteit Brussel, Brussels, 10Department of Respiratory Diseases, University Hospitals Leuven, Leuven, Belgium Introduction: Patients with chronic airway disease may present features of both asthma and COPD, commonly referred to as asthma–COPD overlap syndrome (ACOS). Recommendations on their diagnosis are diffuse and inconsistent. This survey aimed to identify consensus on criteria for diagnosing ACOS.Methods: A Belgian expert panel developed a survey on ACOS diagnosis, which was completed by 87 pulmonologists. Answers chosen by ≥70% of survey respondents were considered as useful criteria for ACOS diagnosis. The two most frequently selected answers were considered as major criteria, others as minor criteria. The expert panel proposed a minimal requirement of two major criteria and one minor criterion for ACOS diagnosis. Respondents were also asked which criteria are important for considering inhaled corticosteroids prescription in a COPD patient.Results: To diagnose ACOS in COPD patients, major criteria were “high degree of variability in airway obstruction over time (change in forced expiratory volume in 1 second ≥400 mL)” and “high degree of response to bronchodilators (>200 mL and ≥12% predicted above baseline)”. Minor criteria were “personal/family history of atopy and/or IgE sensitivity to ≥1 airborne allergen”, “elevated blood/sputum eosinophil levels and/or increased fractional exhaled nitric oxide”, “diagnosis of asthma <40 years of age”; “symptom variability”, and “age (in favor of asthma)”. To diagnose ACOS in asthma patients, major criteria were “persistence of airflow obstruction over time (forced expiratory volume in 1 second/forced vital capacity ratio <0.7)” and “exposure to noxious particles/gases, with ≥10 pack-years for (ex-)smokers”; minor criteria were “lack of response on acute bronchodilator test”; “reduced diffusion capacity”; “limited variability in airway obstruction”; “age >40 years”; “emphysema on chest computed tomography scan”.Conclusion: Specific criteria were identified that may guide physicians to a more uniform diagnostic approach for ACOS in COPD or asthma patients. These criteria are largely similar to those used to prescribe inhaled corticosteroids in COPD. Keywords: ACOS, airway obstruction, asthma, COPD, diagnosis, inhaled corticosteroids 
topic ACOS
airway obstruction
asthma
COPD
diagnosis
inhaled corticosteroids.
url https://www.dovepress.com/a-belgian-survey-on-the-diagnosis-of-asthmandashcopd-overlap-syndrome-peer-reviewed-article-COPD
work_keys_str_mv AT cataldod abelgiansurveyonthediagnosisofasthmandashcopdoverlapsyndrome
AT corhayjl abelgiansurveyonthediagnosisofasthmandashcopdoverlapsyndrome
AT derome abelgiansurveyonthediagnosisofasthmandashcopdoverlapsyndrome
AT louisr abelgiansurveyonthediagnosisofasthmandashcopdoverlapsyndrome
AT marchande abelgiansurveyonthediagnosisofasthmandashcopdoverlapsyndrome
AT michilsa abelgiansurveyonthediagnosisofasthmandashcopdoverlapsyndrome
AT ninanev abelgiansurveyonthediagnosisofasthmandashcopdoverlapsyndrome
AT pecher abelgiansurveyonthediagnosisofasthmandashcopdoverlapsyndrome
AT pilettec abelgiansurveyonthediagnosisofasthmandashcopdoverlapsyndrome
AT vinckenw abelgiansurveyonthediagnosisofasthmandashcopdoverlapsyndrome
AT janssensw abelgiansurveyonthediagnosisofasthmandashcopdoverlapsyndrome
AT cataldod belgiansurveyonthediagnosisofasthmandashcopdoverlapsyndrome
AT corhayjl belgiansurveyonthediagnosisofasthmandashcopdoverlapsyndrome
AT derome belgiansurveyonthediagnosisofasthmandashcopdoverlapsyndrome
AT louisr belgiansurveyonthediagnosisofasthmandashcopdoverlapsyndrome
AT marchande belgiansurveyonthediagnosisofasthmandashcopdoverlapsyndrome
AT michilsa belgiansurveyonthediagnosisofasthmandashcopdoverlapsyndrome
AT ninanev belgiansurveyonthediagnosisofasthmandashcopdoverlapsyndrome
AT pecher belgiansurveyonthediagnosisofasthmandashcopdoverlapsyndrome
AT pilettec belgiansurveyonthediagnosisofasthmandashcopdoverlapsyndrome
AT vinckenw belgiansurveyonthediagnosisofasthmandashcopdoverlapsyndrome
AT janssensw belgiansurveyonthediagnosisofasthmandashcopdoverlapsyndrome
_version_ 1725721115935899648
spelling doaj-0045e8aa811745ecbd3ddf5aca673ecf2020-11-24T22:36:08ZengDove Medical PressInternational Journal of COPD1178-20052017-02-01Volume 1260161331266A Belgian survey on the diagnosis of asthma–COPD overlap syndromeCataldo DCorhay JLDerom ELouis RMarchand EMichils ANinane VPeché RPilette CVincken WJanssens WDidier Cataldo,1 Jean-Louis Corhay,1 Eric Derom,2 Renaud Louis,1 Eric Marchand,3,4 Alain Michils,5 Vincent Ninane,6 Rudi Peché,7 Charles Pilette,8 Walter Vincken,9 Wim Janssens10 1Department of Respiratory Diseases, CHU Liège, University of Liège, Liège, 2Department of Respiratory Medicine, Ghent University Hospital, Ghent, 3Department of Respiratory Medicine, CHU – UCL – Namur, Université catholique de Louvain, Yvoir, 4Molecular Physiology Research Unit (URPhyM)-NARILIS, Laboratory of General Physiology, University of Namur, Namur, 5Chest Department, Erasme University Hospital, Université Libre de Bruxelles, Brussels, 6Department of Respiratory Medicine, University Hospital Saint-Pierre, Université Libre de Bruxelles, Brussels, 7Department of Respiratory Medicine, University Hospital Vésale, Montigny-le-Tilleul, 8Department of Respiratory Medicine, Cliniques universitaires St Luc, Université Catholique de Louvain, Brussels, 9Respiratory Division, University Hospital Brussels (UZ Brussel), Vrije Universiteit Brussel, Brussels, 10Department of Respiratory Diseases, University Hospitals Leuven, Leuven, Belgium Introduction: Patients with chronic airway disease may present features of both asthma and COPD, commonly referred to as asthma–COPD overlap syndrome (ACOS). Recommendations on their diagnosis are diffuse and inconsistent. This survey aimed to identify consensus on criteria for diagnosing ACOS.Methods: A Belgian expert panel developed a survey on ACOS diagnosis, which was completed by 87 pulmonologists. Answers chosen by ≥70% of survey respondents were considered as useful criteria for ACOS diagnosis. The two most frequently selected answers were considered as major criteria, others as minor criteria. The expert panel proposed a minimal requirement of two major criteria and one minor criterion for ACOS diagnosis. Respondents were also asked which criteria are important for considering inhaled corticosteroids prescription in a COPD patient.Results: To diagnose ACOS in COPD patients, major criteria were “high degree of variability in airway obstruction over time (change in forced expiratory volume in 1 second ≥400 mL)” and “high degree of response to bronchodilators (>200 mL and ≥12% predicted above baseline)”. Minor criteria were “personal/family history of atopy and/or IgE sensitivity to ≥1 airborne allergen”, “elevated blood/sputum eosinophil levels and/or increased fractional exhaled nitric oxide”, “diagnosis of asthma <40 years of age”; “symptom variability”, and “age (in favor of asthma)”. To diagnose ACOS in asthma patients, major criteria were “persistence of airflow obstruction over time (forced expiratory volume in 1 second/forced vital capacity ratio <0.7)” and “exposure to noxious particles/gases, with ≥10 pack-years for (ex-)smokers”; minor criteria were “lack of response on acute bronchodilator test”; “reduced diffusion capacity”; “limited variability in airway obstruction”; “age >40 years”; “emphysema on chest computed tomography scan”.Conclusion: Specific criteria were identified that may guide physicians to a more uniform diagnostic approach for ACOS in COPD or asthma patients. These criteria are largely similar to those used to prescribe inhaled corticosteroids in COPD. Keywords: ACOS, airway obstruction, asthma, COPD, diagnosis, inhaled corticosteroids https://www.dovepress.com/a-belgian-survey-on-the-diagnosis-of-asthmandashcopd-overlap-syndrome-peer-reviewed-article-COPDACOSairway obstructionasthmaCOPDdiagnosisinhaled corticosteroids.